Publication date: Oct 14, 2024
Monitoring the number of COVID-19 patients in hospital beds was a critical component of Australia’s real-time surveillance strategy for the disease. From 2021-2023, we produced short-term forecasts of bed occupancy to support public health decision making. In this work, we present a model for forecasting the number of ward and intensive care unit (ICU) beds occupied by COVID-19 cases. The model simulates the stochastic progression of COVID-19 patients through the hospital system and is fit to reported occupancy counts using an approximate Bayesian method. We do not directly model infection dynamics – instead taking independently produced forecasts of case incidence as an input – enabling the independent development of our model from that of the underlying case forecast(s). We evaluate the performance of 21-day forecasts of ward and ICU occupancy across Australia’s eight states and territories between March and September 2022, when major waves of the Omicron variant of SARS-CoV-2 were occurring throughout the country. Forecasts were on average biased downwards immediately prior to epidemic peaks and biased upwards post-peak. Forecast performance was best in jurisdictions with the largest population sizes. Our forecasts of COVID-19 hospital burden were reported weekly to national decision-making committees to support Australia’s public health response.
Concepts | Keywords |
---|---|
Australia | Australia |
Clinical_forecasting_paper | Counts |
July | Covid |
Pandemic | Estimates |
Figure | |
Forecast | |
Forecasts | |
Hospital | |
Icu | |
Medrxiv | |
Occupancy | |
Preprint | |
Produced | |
Reported | |
Ward |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 |
disease | MESH | infection |
disease | IDO | country |
disease | MESH | Infectious Diseases |
drug | DRUGBANK | Abacavir |
drug | DRUGBANK | Esomeprazole |
disease | MESH | clinical progression |
drug | DRUGBANK | Coenzyme M |
disease | IDO | symptom |
drug | DRUGBANK | Trestolone |
disease | MESH | uncertainty |
disease | IDO | process |
drug | DRUGBANK | L-Phenylalanine |
disease | IDO | virulence |
drug | DRUGBANK | Ademetionine |
disease | IDO | algorithm |
drug | DRUGBANK | Methionine |
drug | DRUGBANK | L-Valine |
drug | DRUGBANK | Cysteamine |
drug | DRUGBANK | Etoperidone |
disease | MESH | privacy |